Syndax Pharmaceuticals Reports Fourth Quarter 2021 Financial Results and Provides Clinical and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Syndax Pharmaceuticals Reports Fourth Quarter 2021 Financial Results and Provides Clinical and Business Update

Syndax Pharmaceuticals (SNDX) Tops Q4 EPS, Revenue

March 1, 2022 4:33 PM EST

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q4 EPS of $1.81, $1.53 better than the analyst estimate of $0.28. Revenue for the quarter came in at $126.6 million versus the consensus estimate of $58.68 million.

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.

... More